PRTA Competitors & Alternatives

Compare Prothena Corporation plc with similar stocks in the same industry

Biotechnology

PRTA

Main Stock
$8.20
Tradestie Score
50
Market Cap
$533.99M
Revenue Growth
-0.8%
Analyst Upside
+161.0%

Top Competitors

219 stocks in Biotechnology
Company Price Market Cap P/E Score Action
GLUE Monte Rosa Therapeutics, Inc. Common Stock
$10.84
$463.20M - 47 Compare
SLDB Solid Biosciences Inc. Common Stock
$5.92
$457.09M - 53 Compare
MRVI Maravai LifeSciences Holdings, Inc. Class A Common Stock
$7.32
$454.29M - 56 Compare
RAPT RAPT Therapeutics, Inc. Common Stock
$58.02
$450.49M - 50 Compare
MLTX MoonLake Immunotherapeutics Class A Ordinary Shares
$11.85
$448.32M - 50 Compare
ATXS Astria Therapeutics, Inc. Common Stock
$12.58
$425.52M - 54 Compare
ALMS Alumis Inc. Common Stock
$6.78
$422.50M - 37 Compare
DRUG Bright Minds Biosciences Inc. Common Stock
$52.48
$410.79M - 46 Compare
FDMT 4D Molecular Therapeutics, Inc. Common Stock
$10.80
$407.71M - 53 Compare
DSGN Design Therapeutics, Inc. Common Stock
$10.24
$386.68M - 53 Compare

Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)

219 stocks in this industry